These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16306604)

  • 1. Basic residues in hypervariable region 1 of hepatitis C virus envelope glycoprotein e2 contribute to virus entry.
    Callens N; Ciczora Y; Bartosch B; Vu-Dac N; Cosset FL; Pawlotsky JM; Penin F; Dubuisson J
    J Virol; 2005 Dec; 79(24):15331-41. PubMed ID: 16306604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment.
    Penin F; Combet C; Germanidis G; Frainais PO; Deléage G; Pawlotsky JM
    J Virol; 2001 Jun; 75(12):5703-10. PubMed ID: 11356980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay between basic residues of hepatitis C virus glycoprotein E2 with viral receptors, neutralizing antibodies and lipoproteins.
    Koutsoudakis G; Dragun J; Pérez-Del-Pulgar S; Coto-Llerena M; Mensa L; Crespo G; González P; Navasa M; Forns X
    PLoS One; 2012; 7(12):e52651. PubMed ID: 23300734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies.
    Bartosch B; Verney G; Dreux M; Donot P; Morice Y; Penin F; Pawlotsky JM; Lavillette D; Cosset FL
    J Virol; 2005 Jul; 79(13):8217-29. PubMed ID: 15956567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry.
    Ciczora Y; Callens N; Penin F; Pécheur EI; Dubuisson J
    J Virol; 2007 Mar; 81(5):2372-81. PubMed ID: 17166909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus.
    Prentoe J; Serre SB; Ramirez S; Nicosia A; Gottwein JM; Bukh J
    J Virol; 2014 Feb; 88(3):1725-39. PubMed ID: 24257605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I.
    Voisset C; Callens N; Blanchard E; Op De Beeck A; Dubuisson J; Vu-Dac N
    J Biol Chem; 2005 Mar; 280(9):7793-9. PubMed ID: 15632171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The variable regions of hepatitis C virus glycoprotein E2 have an essential structural role in glycoprotein assembly and virion infectivity.
    McCaffrey K; Gouklani H; Boo I; Poumbourios P; Drummer HE
    J Gen Virol; 2011 Jan; 92(Pt 1):112-21. PubMed ID: 20926639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
    Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T
    J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary study of hepatitis C virus envelope genes during primary infection.
    Chen S; Wang YM
    Chin Med J (Engl); 2007 Dec; 120(24):2174-80. PubMed ID: 18167197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
    Lavillette D; Tarr AW; Voisset C; Donot P; Bartosch B; Bain C; Patel AH; Dubuisson J; Ball JK; Cosset FL
    Hepatology; 2005 Feb; 41(2):265-74. PubMed ID: 15660396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three different functional microdomains in the hepatitis C virus hypervariable region 1 (HVR1) mediate entry and immune evasion.
    Guan M; Wang W; Liu X; Tong Y; Liu Y; Ren H; Zhu S; Dubuisson J; Baumert TF; Zhu Y; Peng H; Aurelian L; Zhao P; Qi Z
    J Biol Chem; 2012 Oct; 287(42):35631-35645. PubMed ID: 22927442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.
    Fénéant L; Potel J; François C; Sané F; Douam F; Belouzard S; Calland N; Vausselin T; Rouillé Y; Descamps V; Baumert TF; Duverlie G; Lavillette D; Hober D; Dubuisson J; Wychowski C; Cocquerel L
    J Virol; 2015 Aug; 89(16):8346-64. PubMed ID: 26041282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry.
    Prentoe J; Bukh J
    Front Immunol; 2018; 9():2146. PubMed ID: 30319614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro adaptation and characterization of attenuated hypervariable region 1 swap chimeras of hepatitis C virus.
    Olesen CH; Augestad EH; Troise F; Bukh J; Prentoe J
    PLoS Pathog; 2021 Jul; 17(7):e1009720. PubMed ID: 34280245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
    Bartosch B; Vitelli A; Granier C; Goujon C; Dubuisson J; Pascale S; Scarselli E; Cortese R; Nicosia A; Cosset FL
    J Biol Chem; 2003 Oct; 278(43):41624-30. PubMed ID: 12913001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly hydrophobic domain within hypervariable region 1 may be related to the entry of hepatitis C virus into cultured human hepatoma cells.
    Kurihara C; Tsuzuki Y; Hokari R; Nakashima H; Mataki N; Kuroki M; Kawaguchi A; Nagao S; Kondo T; Miura S
    J Med Virol; 2004 Dec; 74(4):546-55. PubMed ID: 15484277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Optimized Hepatitis C Virus E2 Glycoprotein Core Adopts a Functional Homodimer That Efficiently Blocks Virus Entry.
    McCaffrey K; Boo I; Owczarek CM; Hardy MP; Perugini MA; Fabri L; Scotney P; Poumbourios P; Drummer HE
    J Virol; 2017 Mar; 91(5):. PubMed ID: 28031364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.
    Cowton VM; Angus AGN; Cole SJ; Markopoulou CK; Owsianka A; Dunlop JI; Gardner DE; Krey T; Patel AH
    J Virol; 2016 Aug; 90(16):7456-7468. PubMed ID: 27279607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.